Article Information
History
- April 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Kevin M. Brown1,*,
- Mai Xu1,*,
- Michael Sargen1,
- Hyunbum Jang2,
- Mingzhen Zhang2,
- Tongwu Zhang1,
- Bin Zhu1,
- Kristie Jones1,
- Jung Kim1,
- Laura Mendoza1,
- Nicholas K. Hayward3,
- Margaret A. Tucker1,
- Alisa M. Goldstein1,
- Xiaohong Rose Yang1,
- Douglas R. Stewart1,
- Belynda Hicks1,
- Dario Consonni4,
- Angela C. Pesatori4,5,
- Maria Concetta Fargnoli6,
- Ketty Peris7,
- Alex Stratigos8,
- Chiara Menin9,
- Paola Ghiorzo10,
- Susana Puig11,
- Eduardo Nagore12,
- MelaNostrum Consortium^,
- Thorkell Andresson2,
- Ruth Nussinov2,13,
- Donato Calista14 and
- Maria Teresa Landi1,†
- 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD USA
- 2Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick MD USA
- 3Oncogenomics Laboratory, QIMR Berghofer Research Institute, Brisbane, Australia
- 4Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Occupational Health Unit, Milan, Italy
- 5Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
- 6Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
- 7Institute of Dermatology, Catholic University, Rome, Italy
- 8Department of Dermatology, Andreas Syggros Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 9Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
- 10IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy and Department of Internal Medicine and Medical Specialties, University of Genoa, Italy
- 11Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERER, Barcelona, Spain
- 12Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain
- 13Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
- 14Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy
- ↵†Address correspondence to: Maria Teresa Landi, MD, PhD, Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, EPS 7106, Bethesda, MD 20892, E-mail: landim{at}mail.nih.gov, Phone: 240-276-7236, Cell: 301-978-1406
↵* These authors contributed equally to this work.
Posted April 20, 2021.
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
